DrugCite
Search

SOLU DECORTIN H

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Solu Decortin H Adverse Events Reported to the FDA Over Time

How are Solu Decortin H adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Solu Decortin H, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Solu Decortin H is flagged as the suspect drug causing the adverse event.

Most Common Solu Decortin H Adverse Events Reported to the FDA

What are the most common Solu Decortin H adverse events reported to the FDA?

Stevens-johnson Syndrome
11 (6.15%)
Urinary Tract Infection
11 (6.15%)
Leukopenia
10 (5.59%)
Toxic Epidermal Necrolysis
10 (5.59%)
Urosepsis
9 (5.03%)
Pneumonia
6 (3.35%)
Pyrexia
6 (3.35%)
Blood Creatinine Increased
5 (2.79%)
Renal Failure
5 (2.79%)
Cytomegalovirus Infection
4 (2.23%)
Hepatic Neoplasm Malignant
4 (2.23%)
Show More Show More
Kidney Transplant Rejection
4 (2.23%)
Asphyxia
3 (1.68%)
Herpes Zoster
3 (1.68%)
Ileus
3 (1.68%)
Lung Adenocarcinoma
3 (1.68%)
Nausea
3 (1.68%)
Shock
3 (1.68%)
Transplant Rejection
3 (1.68%)
Ascites
2 (1.12%)
Blister
2 (1.12%)
Dialysis
2 (1.12%)
General Physical Health Deteriorati...
2 (1.12%)
Graft Loss
2 (1.12%)
Hot Flush
2 (1.12%)
Hypokalaemia
2 (1.12%)
Loss Of Consciousness
2 (1.12%)
Metastases To Peritoneum
2 (1.12%)
Nephrectomy
2 (1.12%)
Oedema
2 (1.12%)
Pain
2 (1.12%)
Pupil Fixed
2 (1.12%)
Rash
2 (1.12%)
Rash Macular
2 (1.12%)
Renal Vein Thrombosis
2 (1.12%)
Respiratory Arrest
2 (1.12%)
Respiratory Failure
2 (1.12%)
Sleep Disorder
2 (1.12%)
Urinary Retention
2 (1.12%)
Adrenal Adenoma
1 (.56%)
Anaphylactic Reaction
1 (.56%)
Bronchitis
1 (.56%)
Cold Sweat
1 (.56%)
Complications Of Transplanted Kidne...
1 (.56%)
Constipation
1 (.56%)
Dyskinesia
1 (.56%)
Dyspnoea
1 (.56%)
Enzyme Abnormality
1 (.56%)
Extrapyramidal Disorder
1 (.56%)
Fungal Infection
1 (.56%)
Gastroenteritis
1 (.56%)
Gastrointestinal Disorder
1 (.56%)
Gastrooesophageal Reflux Disease
1 (.56%)
General Physical Condition Abnormal
1 (.56%)
Genital Erosion
1 (.56%)
Human Polyomavirus Infection
1 (.56%)
Hypersensitivity
1 (.56%)
Hypertension
1 (.56%)
Infection
1 (.56%)
Lip Erosion
1 (.56%)
Liver Transplant
1 (.56%)
Liver Transplant Rejection
1 (.56%)
Lung Adenocarcinoma Metastatic
1 (.56%)
Malaise
1 (.56%)
Mucosal Erosion
1 (.56%)
Mucosal Inflammation
1 (.56%)
Ocular Hyperaemia
1 (.56%)
Oral Mucosa Erosion
1 (.56%)
Protein Total Abnormal
1 (.56%)
Restless Legs Syndrome
1 (.56%)
Skin Lesion
1 (.56%)
Urethral Stenosis
1 (.56%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Solu Decortin H, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Solu Decortin H is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Solu Decortin H

What are the most common Solu Decortin H adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Solu Decortin H, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Solu Decortin H is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Solu Decortin H According to Those Reporting Adverse Events

Why are people taking Solu Decortin H, according to those reporting adverse events to the FDA?

Prophylaxis
7
Chronic Obstructive Airways Disease
7
Immunosuppression
5
Renal Transplant
4
Vascular Injury
3
Premedication
3
Show More Show More
Effusion
3
Drug Use For Unknown Indication
2
Skin Disorder
2
Prophylactic Chemotherapy
2
Breast Cancer Metastatic
2
Rash
2
Stridor
2
Sepsis
2
Asthma
2
Colitis Ulcerative
2
Prophylaxis Against Transplant Reje...
1
Pneumocystis Carinii Pneumonia
1
Product Used For Unknown Indication
1
Hypersensitivity
1
Acute Myeloid Leukaemia
1
Sinusitis
1

Solu Decortin H Case Reports

What Solu Decortin H safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Solu Decortin H. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Solu Decortin H.